[ad_1]
SINGAPORE: Singapore reported five new cases of COVID-19 as of noon on Monday (Nov 23), the Ministry of Health (MINSA) said.
All cases were imported and placed on a stay-at-home notice or isolated upon arrival in Singapore, the Health Ministry added.
There were no cases of local transmission for the thirteenth consecutive day.
The five imported cases were asymptomatic. Among them is a 16-year-old Singaporean who returned from India.
READ: Travel bubble postpones joint decision by Singapore and Hong Kong, says Chan Chun Sing
Three others are work permit holders currently working in Singapore and came from Indonesia.
The remaining case is a holder of a short-term visitation pass that arrived from France. The 58-year-old is an engineer on a job project in Singapore, the Health Ministry said.
FOUR MORE DOWNLOADS
Four more cases have been discharged from hospitals or community isolation facilities, bringing Singapore’s total recoveries to 58,071.
There are 36 COVID-19 patients still in the hospital. Most of them are stable or improving and one is in critical condition in the intensive care unit.
READ: Hong Kong and Singapore bubble delay highlights obstacles to travel recovery
Another 30 cases are isolated and treated in community facilities. These are people who have mild symptoms or are clinically well, but still test positive for COVID-19.
The Health Ministry said the total number of new cases in the community has remained low, with no new cases in the last week. More details can be found in the daily situation report of the Ministry of Health.
As of Monday, Singapore has reported 58,165 COVID-19 cases and 28 deaths from the disease.
POSSIBLE DEVELOPMENT OF VACCINES IN DECEMBER IN USA, UK
The United States expects to begin a comprehensive COVID-19 vaccination program in early December with approval from the Food and Drug Administration, the head of the government’s coronavirus vaccination effort, Moncef Slaoui, said Sunday.
Reportedly, FDA vaccine advisers will meet Dec. 10 to discuss approval of vaccines that pharmaceutical firms Pfizer and Moderna say are at least 95 percent effective.
READ: The vaccine will not be enough to stop the COVID-19 pandemic: WHO chief
Britain could also give regulatory approval to Pfizer-BioNTech’s COVID-19 vaccine this week, even before the United States authorizes it, news site Telegraph reported.
Citing government sources, he said British regulators were about to begin a formal evaluation of the vaccine and that the National Health Service had been told to be ready to administer it before December 1.
G20 leaders said Sunday they will “spare no effort” to ensure the fair distribution of coronavirus vaccines around the world and to support poor countries whose economies have been devastated by the crisis.
The new coronavirus has killed at least 1.3 million people and infected more than 58 million since the outbreak emerged in China last December.
CHECK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments
Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram
